2023
Risk of melanoma and nonmelanoma skin cancer with immunosuppressants, part I: Calcineurin inhibitors, thiopurines, IMDH inhibitors, mTOR inhibitors, and corticosteroids.
Journal of the American Academy of Dermatology
PubMed • Publisher's siteResearch at a glance
Top areas of exploration
- Skin Neoplasms , 20 publications
- Melanoma , 8 publications
- Organ Transplantation , 5 publications
- Carcinoma, Squamous Cell , 4 publications
Research activity
My publications
Filter publications
50 publications
2023
Risk of melanoma and nonmelanoma skin cancer with immunosuppressants, part II: Methotrexate, alkylating agents, biologics, and small molecule inhibitors.
Journal of the American Academy of Dermatology
PubMed • Publisher's site2021
A photodistributed eruption in an immunosuppressed patient.
JAAD case reports
PubMed • Publisher's site2021
Basal Cell Carcinoma Arising in Scars of Subcutaneous Port Sites.
Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
PubMed • Publisher's site2021
Reactive angioendotheliomatosis associated with antiphospholipid syndrome.
Dermatology online journal
PubMed